Beckman Coulter Life Sciences is taking actions in the best interests of our associates, customers, and business partners as we navigate the growing threats of the 2019 Novel Coronavirus disease (COVID-19). Learn more
One of the most important steps in drug development, lead identification and optimization occurs on the resulting hit-to-lead high throughput screening experiments. During lead optimization, whether working on small molecule or biologics, efficacy and toxicity profiles of the target are critical. Pharmacokinetic and pharmacodynamic properties are assessed for small molecules during this phase.
Oops. The page you wanted could not be found, so we brought you to something similar. If you still can't find what you want, try searching our site instead.
